Sign in

CIK 0001770121

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Sana Biotechnology, Inc.

Sign in to watch
Ticker
SANA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831381173
Phone
+1 206-701-7914
Business address
188 EAST BLAINE STREET, SUITE 350, SEATTLE, WA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-02-08 NELSEN ROBERT Director Conversion · Series B Convertible Preferred Stock −2,343,750 0
2021-02-08 NELSEN ROBERT Director Conversion · Series B Convertible Preferred Stock −2,343,750 0
2021-02-08 Harr Steve President & CEO Conversion +2,031,250 8,173,750
2021-02-08 Harr Steve President & CEO Conversion · Series A-1 Convertible Preferred Stock −1,075,000 0
2021-02-08 Harr Steve President & CEO Conversion · Series A-2 Convertible Preferred Stock −800,000 0
2021-02-08 Harr Steve President & CEO Conversion · Series B Convertible Preferred Stock −156,250 0
2021-02-08 von Maltzahn Geoffrey Director Conversion +1,464,488 1,464,488
2021-02-08 von Maltzahn Geoffrey Director Conversion +366,122 366,122
2021-02-08 von Maltzahn Geoffrey Director Conversion · Series A-2 Convertible Preferred Stock −1,464,488 0
2021-02-08 von Maltzahn Geoffrey Director Conversion · Series A-2 Convertible Preferred Stock −366,122 0
2021-02-08 MacDonald James J. See Remarks Conversion +93,750 428,750
2021-02-08 MacDonald James J. See Remarks Conversion +7,812 7,812
2021-02-08 MacDonald James J. See Remarks Conversion · Series A-1 Convertible Preferred Stock −93,750 0
2021-02-08 MacDonald James J. See Remarks Conversion · Series B Convertible Preferred Stock −7,812 0
2021-02-03 Bilenker Joshua H. Director Purchase +20,000 $25.00 $500K 20,000
2021-02-03 von Maltzahn Geoffrey Director Grant or award · Stock Option (Right to Buy) +23,591 23,591
2021-02-03 Bishop Hans Edgar Director Grant or award · Stock Option (Right to Buy) +23,591 23,591
2021-02-03 REICIN ALISE Director Grant or award · Stock Option (Right to Buy) +11,795 11,795
2021-02-03 Bilenker Joshua H. Director Grant or award · Stock Option (Right to Buy) +11,795 11,795
2021-02-03 Wilderotter Mary Agnes Director Grant or award · Stock Option (Right to Buy) +23,591 23,591

Page 15 of 16 · 315 trades